Gerardo Botti

27.9k citations
541 papers · 14.9k indexed · 1 hit paper · h-index 60

Impact in

  • Oncology top 0.2%
    • Cancer Immunotherapy and Biomarkers
    • Cutaneous Melanoma Detection and Management
    • Cancer Cells and Metastasis
    • Cancer-related molecular mechanisms research
    • Cancer Genomics and Diagnostics

Papers in

    • Cutaneous Melanoma Detection and Management 41
    • Cancer Immunotherapy and Biomarkers 35
    • Colorectal Cancer Treatments and Studies 23
    • Cancer Genomics and Diagnostics 37
    • Breast Cancer Treatment Studies 27

Gerardo Botti

526 papers receiving 14.7k citations

Hit Papers

The SGLT-2 inhibitor empagliflozin improves myocardial strain, reduces cardiac fibrosis and pro-inflammatory cytokines in non-diabetic mice treated with doxorubicin 2021 · 268 citations
268202120262022202450100150200250

Peers

Gerardo Botti
Comparison fields: 5 of 178
  • Oncology 6.7k
  • Cancer Research 3.4k
  • Immunology 1.8k
  • Molecular Biology 5.2k
  • Immunology and Allergy 429
Replace David R. Byrd with:
David R. Byrd United States
Thomas S. Murray United States
Hitoshi Tsuda Japan
Christoph Röcken Germany
Masashi Fukayama Japan
Katherine S. Panageas United States
Ian A. Cree United Kingdom
Atsushi Ochiai Japan
Emile E. Voest Netherlands
Kohzoh Imai Japan
Gerardo Botti relative to David R. Byrd United States David R. Byrd's profile →
Citations per field
00.5×1.5×
David R. Byrd · 1×
Citations per year

Countries citing papers authored by Gerardo Botti

Since Specialization
Citations

This map shows the geographic impact of Gerardo Botti's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gerardo Botti with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gerardo Botti more than expected).

Fields of papers citing papers by Gerardo Botti

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gerardo Botti. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gerardo Botti. The network helps show where Gerardo Botti may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Gerardo Botti, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Gerardo Botti Line = papers co-authored together Gerardo Botti links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown
#Work
1 20250
2 20251
3 20240
4 20226
5 20219
6 202024
7 202035
8 202024
9 201939
10 201927
11 20199
12
Multimodal approaches and tailored therapies for pain management: the trolley analgesic model
201913
13 201910
14 201928
15 201853
16 201857
17 201746
18 201634
19 201615
20 2012360

About Gerardo Botti

Gerardo Botti is a scholar working on Oncology, Cancer Research, Dermatology, Immunology and Allergy and Immunology, having authored 541 papers that have together received 14.9k indexed citations. Recurring topics across this work include Immunotherapy and Immune Responses (42 papers), Cutaneous Melanoma Detection and Management (41 papers), Cancer Genomics and Diagnostics (37 papers), Cancer Immunotherapy and Biomarkers (35 papers), Facial Rejuvenation and Surgery Techniques (28 papers), Melanoma and MAPK Pathways (27 papers), Breast Cancer Treatment Studies (27 papers) and Colorectal Cancer Treatments and Studies (23 papers). The work is most often cited by research in Oncology (6.7k citations), Cancer Research (3.4k citations), Immunology (1.8k citations), Molecular Biology (5.2k citations) and Immunology and Allergy (429 citations). Gerardo Botti has collaborated with scholars based in Italy, United States and Malaysia. Frequent co-authors include Monica Cantile, Paolo A. Ascierto, Renato Franco, Maurizio Di Bonito, Giuseppe D’Aiuto, Giosuè Scognamiglio, Michelino De Laurentiis, Fabiana Tatangelo, Corrado Caracò and Francesca Collina. Their work appears in journals such as Journal of Translational Medicine, Oncotarget, Journal of Clinical Oncology, Cancers and International Journal of Molecular Sciences.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026